» Articles » PMID: 16431192

Racial Differences in Blood Pressure Control: Potential Explanatory Factors

Overview
Journal Am J Med
Specialty General Medicine
Date 2006 Jan 25
PMID 16431192
Citations 125
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Poor blood pressure control remains a common problem that contributes to significant cardiovascular morbidity and mortality, particularly among African Americans. We explored antihypertensive medication adherence and other factors that may explain racial differences in blood pressure control.

Methods: Baseline data were obtained from the Veteran's Study to Improve The Control of Hypertension, a randomized controlled trial designed to improve blood pressure control. Clinical, demographic, and psychosocial factors relating to blood pressure control were examined.

Results: A total of 569 patients who were African American (41%) or white (59%) were enrolled in the study. African Americans were more likely to have inadequate baseline blood pressure control than whites (63% vs 50%; odds ratio = 1.70; 95% confidence interval [CI] 1.20-2.41). Among 20 factors related to blood pressure control, African Americans also had a higher odds ratio of being nonadherent to their medication, being more functionally illiterate, and having a family member with hypertension compared with whites. Compared with whites, African Americans also were more likely to perceive high blood pressure as serious and to experience the side effect of increased urination compared with whites. Adjusting for these differences reduced the odds ratio of African Americans having adequate blood pressure control to 1.59 (95% confidence interval 1.09-2.29).

Conclusions: In this sample of hypertensive patients who have good access to health care and medication benefits, African Americans continued to have lower levels of blood pressure control despite considering more than 20 factors related to blood pressure control. Interventions designed to improve medication adherence need to take race into account. Patients' self-reports of failure to take medications provide an opportunity for clinicians to explore reasons for medication nonadherence, thereby improving adherence and potentially blood pressure control.

Citing Articles

Comparative Effectiveness of Calcium-Channel Blockers, Angiotensin-Converting Enzyme/Angiotensin Receptor Blockers and Diuretics on Cardiovascular Events Likelihood in Hypertensive African-American and Non-Hispanic Caucasians: A Retrospective Study....

Harrison A, Rayamajhi S, Shaker F, Thais S, Moreno M, Hosseini K Clin Cardiol. 2025; 48(1):e70075.

PMID: 39835349 PMC: 11747351. DOI: 10.1002/clc.70075.


Incident Epilepsy Among US Medicare Beneficiaries, 2019: Differences by Age, Sex, and Race/Ethnicity.

Warner D, Fein H, Schiltz N, Vu L, Szaflarski M, Bensken W Neurology. 2024; 103(7):e209804.

PMID: 39250748 PMC: 11385955. DOI: 10.1212/WNL.0000000000209804.


Predictors of chronic kidney disease survival in type 2 diabetes: a 12-year retrospective cohort study utilizing estimated glomerular filtration rate.

Jairoun A, Ping C, Ibrahim B Sci Rep. 2024; 14(1):9014.

PMID: 38641627 PMC: 11031608. DOI: 10.1038/s41598-024-58574-x.


Trends of Antihypertensive Prescription Among US Adults From 2010 to 2019 and Changes Following Treatment Guidelines: Analysis of Multicenter Electronic Health Records.

Lin P, Rifas-Shiman S, Merriman J, Petimar J, Yu H, Daley M J Am Heart Assoc. 2024; 13(9):e032197.

PMID: 38639340 PMC: 11179868. DOI: 10.1161/JAHA.123.032197.


Factors associated with chronic kidney disease in patients with diabetes in French Guiana.

Sacareau C, Nacher M, Alsibai K, Ntoutoum A, Adenis A, Hounnou M Front Clin Diabetes Healthc. 2023; 4:1167852.

PMID: 37953925 PMC: 10634610. DOI: 10.3389/fcdhc.2023.1167852.